Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America

Linda M. Liau (Herausgeber)

Buch | Hardcover

240 Seiten

2021
Elsevier - Health Sciences Division (Verlag)
978-0-323-81305-1 (ISBN)

Infos

This issue of Neurosurgery Clinics, guest edited by Dr. Linda M. Liau, is dedicated to Glioblastoma: Molecular and Clinical Trials. This issue is one of four selected each year by the series consulting editors, Drs. Russell R. Lonser and Daniel K. Resnick. Topics will include-but are not limited to-Pathology & Molecular Markers, Cellular States & Genetic Diversity in Glioblastoma, Mismatch Repair in Glioblastoma Resistance, Genetic Susceptibility in Brain Cancer, Pediatric Gliomas: Molecular Landscape & Emerging Targets, Molecularly Targeted Clinical Trials, Novel Radiation Sensitizers, Immunotherapy Checkpoint Inhibitors, Brain Tumor Vaccines, CAR T Cells, Oncolytic Virotherapy, Targeting Cancer Stem Cells, Therapeutic Delivery to CNS, Theranostics: Dual Modality PET Tracers, and Neuroimaging & Novel Response Assessments.

Produkt-Details

• Erscheinungsdatum: 23.04.2021
• Reihe/Serie: The Clinics: Surgery
• Verlagsort: Philadelphia
• Sprache: englisch
• Maße: 178 x 254 mm
• Gewicht: 570 g
• Themenwelt: Medizinische Fachgebiete ► Chirurgie ► Neurochirurgie
• ISBN-10: 0-323-81305-4 / 0323813054
• ISBN-13: 978-0-323-81305-1 / 9780323813051
• Zustand: Neuware